Contemporary Oncology

eISSN: 1897-4309
ISSN: 1428-2526

Contemporary Oncology/Współczesna Onkologia

Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

IMPACT FACTOR

1.8

MNiSW

Indexed in:

ESCI

Web of Science
Clarivate Analytics

JCI

0.24

Journal Citation Indicator

CiteScore 2022

2.4

Join us at Facebook!

2/2022
vol. 26

Review paper

Current indications and patient selection for transoral robotic surgery in head and neck cancer: a brief review

Patryk Niewinski, Wojciech Jerzy Golusiński

Contemp Oncol (Pozn) 2022; 26 (2): 91–96

Online publish date: 2022-07-08

DOI : https://doi.org/10.5114/wo.2022.118240

Abstract Full text

Original paper

Biopsychosocial impact on caregivers of head and neck cancer patients undergoing radiotherapy at a tertiary care hospital

Praveen Jodalli, Arya Raju, Amitha Basheer N

Contemp Oncol (Pozn) 2022; 26: 97–101

Online publish date: 2022-05-12

DOI : https://doi.org/10.5114/wo.2022.116275

Abstract Full text

Original paper

Outcome after implementation of a clinical pathway for pancreaticoduodenectomy in a low volume centre

Thomas Zacharias, Dan Sebastien, Ferreira Nelio

Contemp Oncol (Pozn) 2022; 26: 102–108

Online publish date: 2022-06-20

DOI : https://doi.org/10.5114/wo.2022.117359

Abstract Full text

Original paper

RON, ROR1 and SUSD2 expression in tissues of endometrial carcinoma patients. Clinicopathological and prognostic implications

Abeer M. Abdelbary, Randa Mohamed Kaf, Mohamed Elbakry Lashin, Ahmed Z. Alattar, Dalia Hamouda Elsayed, Ahmed F. Amin, Loay M. Gertallah, Ahmed Mohamed Yehia

Contemp Oncol (Pozn) 2022; 26 (2): 109–122

Online publish date: 2022-06-30

DOI : https://doi.org/10.5114/wo.2022.118245

Abstract Full text

Original paper

Cluster analysis of deterioration sites after first-line epidermal growth factor receptor-tyrosine kinase inhibitor in epidermal growth factor receptor mutated non-small cell lung cancer

Shinichiro Okauchi, Kunihiko Miyazaki, Hiroaki Satoh

Contemp Oncol (Pozn) 2022; 26 (2): 123–127

Online publish date: 2022-06-30

DOI : https://doi.org/10.5114/wo.2022.118195

Abstract Full text

Original paper

Quantitative analysis of plasma DNA in anal cancer patients

Ewa Małusecka, Monika Giglok, Rafał Suwiński, Tomasz Wojciech Rutkowski, Agnieszka Maria Mazurek

Contemp Oncol (Pozn) 2022; 26 (2): 128–132

Online publish date: 2022-06-30

DOI : https://doi.org/10.5114/wo.2022.118132

Abstract Full text

Original paper

Examining the use of abdominal compression in stereotactic body radiotherapy for liver metastases: a single center’s experience of 10 years

Cenk Ahmet Sen

Contemp Oncol (Pozn) 2022; 26 (2): 133–138

Online publish date: 2022-06-30

DOI : https://doi.org/10.5114/wo.2022.118121

Abstract Full text

Original paper

Lymphovascular invasion in hormone-positive, human epidermal growth factor-negative, low-burden axillary disease in early breast cancer patients tested for oncotype DX recurrence score

Abdalla Saad Abdalla Al-Zawi, Su Lei Yin, Zina Aladili

Contemp Oncol (Pozn) 2022; 26 (2): 139–143

Online publish date: 2022-07-08

DOI : https://doi.org/10.5114/wo.2022.118220

Abstract Full text

Original paper

An analysis of the significance of the lymph node ratio and extracapsular involvement in the prognosis of endometrial cancer patients

Katarzyna Gorzelnik, Sebastian Szubert, Anna Knafel, Anna Wójcikiewicz, Błażej Nowakowski, Krzysztof Koper, Łukasz Wicherek

Contemp Oncol (Pozn) 2022; 26 (2): 144–149

Online publish date: 2022-06-30

DOI : https://doi.org/10.5114/wo.2022.118243

Abstract Full text

Original paper

Trends of colorectal cancer in a central area of Iran during 2009–2014. An application of joinpoint regression

Rahmatollah Moradzadeh, Shahla Mirgaloybayat

Contemp Oncol (Pozn) 2022; 26 (2): 150–154

Online publish date: 2022-06-30

DOI : https://doi.org/10.5114/wo.2022.118213

Abstract Full text

Letter to the Editor

Nivolumab and ipilimumab therapy in a patient with non-small cell lung cancer with chronic kidney disease

Hiroaki Satoh, Sou Hattori

Contemp Oncol (Pozn) 2022; 26 (2): 155–156

Online publish date: 2022-06-30

DOI : https://doi.org/10.5114/wo.2022.118004

Full text